-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Raphael Pharmaceutical Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2025.
- Raphael Pharmaceutical Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$251K, a 21.3% increase year-over-year.
- Raphael Pharmaceutical Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$1.39M, a 33% decline year-over-year.
- Raphael Pharmaceutical Inc. annual Operating Income (Loss) for 2024 was -$1.51M, a 13.3% decline from 2023.
- Raphael Pharmaceutical Inc. annual Operating Income (Loss) for 2023 was -$1.33M, a 59.8% increase from 2022.
- Raphael Pharmaceutical Inc. annual Operating Income (Loss) for 2022 was -$3.32M, a 104% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)